Suppr超能文献

BTG1 抗增殖蛋白的构象转变及其疾病突变体的调节。

Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants.

机构信息

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.

Division of Hematology/Oncology, Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.

出版信息

Biophys J. 2022 Oct 4;121(19):3753-3764. doi: 10.1016/j.bpj.2022.04.023. Epub 2022 Apr 21.

Abstract

B cell translocation gene 1 (BTG1) protein belongs to the BTG/transducer of ERBB2 (TOB) family of antiproliferative proteins whose members regulate various key cellular processes such as cell cycle progression, apoptosis, and differentiation. Somatic missense mutations in BTG1 are found in ∼70% of a particularly malignant and disseminated subtype of diffuse large B cell lymphoma (DLBCL). Antiproliferative activity of BTG1 has been linked to its ability to associate with transcriptional cofactors and various enzymes. However, molecular mechanisms underlying these functional interactions and how the disease-linked mutations in BTG1 affect these mechanisms are currently unknown. To start filling these knowledge gaps, here, using atomistic molecular dynamics (MD) simulations, we explored structural, dynamic, and kinetic characteristics of BTG1 protein, and studied how various DLBCL mutations affect these characteristics. We focused on the protein region formed by α2 and α4 helices, as this interface has been reported not only to serve as a binding hotspot for several cellular partners but also to harbor sites for the majority of known DLBCL mutations. Markov state modeling analysis of extensive MD simulations revealed that the α2-α4 interface in the wild-type (WT) BTG1 undergoes conformational transitions between closed and open metastable states. Importantly, we show that some of the mutations in this region that are observed in DLBCL, such as Q36H, F40C, Q45P, E50K (in α2), and A83T and A84E (in α4), either overstabilize one of these two metastable states or give rise to new conformations in which these helices are distorted (i.e., kinked or unfolded). Based on these results, we conclude that the rapid interconversion between the closed and open conformations of the α2-α4 interface is an essential component of the BTG1 functional dynamics that can prime the protein for functional associations with its binding partners. Disruption of the native dynamic equilibrium by DLBCL mutants leads to the ensemble of conformations in BTG1 that are unlikely structurally and/or kinetically to enable productive functional interactions with the binding proteins.

摘要

B 细胞易位基因 1(BTG1)蛋白属于 BTG/表皮生长因子受体 2 转导物(TOB)家族的抗增殖蛋白,其成员调节细胞周期进程、细胞凋亡和分化等各种关键细胞过程。BTG1 中的体细胞错义突变存在于弥漫性大 B 细胞淋巴瘤(DLBCL)的一种特别恶性和扩散的亚型中约 70%。BTG1 的抗增殖活性与其与转录共因子和各种酶结合的能力有关。然而,目前尚不清楚这些功能相互作用的分子机制以及 BTG1 中的疾病相关突变如何影响这些机制。为了开始填补这些知识空白,在这里,我们使用原子分子动力学(MD)模拟,探索了 BTG1 蛋白的结构、动态和动力学特性,并研究了各种 DLBCL 突变如何影响这些特性。我们专注于由 α2 和 α4 螺旋形成的蛋白质区域,因为该界面不仅被报道不仅是几个细胞伴侣的结合热点,而且还含有大多数已知的 DLBCL 突变的位点。对广泛的 MD 模拟的马尔可夫状态建模分析表明,野生型(WT)BTG1 中的 α2-α4 界面在封闭和开放亚稳状态之间经历构象转变。重要的是,我们表明,在 DLBCL 中观察到的该区域的一些突变,如 Q36H、F40C、Q45P、E50K(在 α2 中)和 A83T 和 A84E(在 α4 中),要么过度稳定这两种亚稳状态之一,要么导致这些螺旋扭曲(即,弯曲或展开)的新构象。基于这些结果,我们得出结论,α2-α4 界面的封闭和开放构象之间的快速转换是 BTG1 功能动力学的一个重要组成部分,它可以使蛋白质为与结合伴侣的功能关联做好准备。DLBCL 突变体对天然动态平衡的破坏导致 BTG1 中存在的构象集合在结构上和/或动力学上不太可能与结合蛋白进行有成效的功能相互作用。

相似文献

1
BTG1 抗增殖蛋白的构象转变及其疾病突变体的调节。
Biophys J. 2022 Oct 4;121(19):3753-3764. doi: 10.1016/j.bpj.2022.04.023. Epub 2022 Apr 21.
2
BTG/Tob家族的抗增殖蛋白被泛素-蛋白酶体系统降解。
Eur J Biochem. 2002 Jul;269(14):3596-604. doi: 10.1046/j.1432-1033.2002.03052.x.
4
BTG1 失活通过激活 BCAR1 驱动淋巴瘤发生和促进淋巴瘤播散。
Blood. 2023 Mar 9;141(10):1209-1220. doi: 10.1182/blood.2022016943.
6
Btg1和Btg2在膜免疫球蛋白结合后通过精氨酸甲基化作用于WEHI-231细胞生长停滞中的作用。
Exp Cell Res. 2007 Jul 1;313(11):2356-66. doi: 10.1016/j.yexcr.2007.03.021. Epub 2007 Mar 30.
8
B细胞易位1基因抑制乳腺癌细胞的转移相关行为。
Mol Med Rep. 2014 Jun;9(6):2374-80. doi: 10.3892/mmr.2014.2118. Epub 2014 Apr 4.
10
非霍奇金淋巴瘤中 BTG1 活性频繁丧失及与 Ccr4-Not 脱腺苷酸酶 Caf1 亚基相互作用受损。
Leuk Lymphoma. 2021 Feb;62(2):281-290. doi: 10.1080/10428194.2020.1827243. Epub 2020 Oct 6.

引用本文的文献

1
原发性中枢神经系统淋巴瘤疾病进展和生存的基因组生物标志物的鉴定。
Blood Adv. 2025 Mar 11;9(5):1117-1131. doi: 10.1182/bloodadvances.2024014460.
2
弥漫性大 B 细胞淋巴瘤的小鼠模型。
Front Immunol. 2023 Dec 6;14:1313371. doi: 10.3389/fimmu.2023.1313371. eCollection 2023.
3
突变产生了超竞争的 B 细胞,这些细胞为恶性转化做好了准备。
Science. 2023 Jan 20;379(6629):eabj7412. doi: 10.1126/science.abj7412.
4
基于结构的蛋白质动力学建模与机器学习方法的互利融合。
Curr Opin Struct Biol. 2023 Feb;78:102517. doi: 10.1016/j.sbi.2022.102517. Epub 2022 Dec 30.
5
癌症生物物理学
Biophys J. 2022 Oct 4;121(19):E1-E2. doi: 10.1016/j.bpj.2022.09.017. Epub 2022 Sep 23.

本文引用的文献

2
马尔可夫状态模型能做什么与不能做什么:蛋白质折叠模型中基于相关性与基于路径的可观测量
J Chem Theory Comput. 2021 May 11;17(5):3119-3133. doi: 10.1021/acs.jctc.0c01154. Epub 2021 Apr 27.
3
非霍奇金淋巴瘤中 BTG1 活性频繁丧失及与 Ccr4-Not 脱腺苷酸酶 Caf1 亚基相互作用受损。
Leuk Lymphoma. 2021 Feb;62(2):281-290. doi: 10.1080/10428194.2020.1827243. Epub 2020 Oct 6.
4
大规模的 tethered 功能测定可鉴定调控 mRNA 稳定性和翻译的因子。
Nat Struct Mol Biol. 2020 Oct;27(10):989-1000. doi: 10.1038/s41594-020-0477-6. Epub 2020 Aug 17.
5
BTG1 和 BTG2 通过 mRNA 不稳定性维持 T 细胞静止。
Science. 2020 Mar 13;367(6483):1255-1260. doi: 10.1126/science.aax0194.
6
肿瘤抑制因子 BTG1 和 BTG2:超越生长控制。
J Cell Physiol. 2019 May;234(5):5379-5389. doi: 10.1002/jcp.27407. Epub 2018 Oct 23.
7
OpenMM 7:分子动力学高性能算法的快速开发。
PLoS Comput Biol. 2017 Jul 26;13(7):e1005659. doi: 10.1371/journal.pcbi.1005659. eCollection 2017 Jul.
9
BTG4 是卵母细胞中减数分裂细胞周期偶联的母-合子过渡许可因子。
Nat Struct Mol Biol. 2016 May;23(5):387-94. doi: 10.1038/nsmb.3204. Epub 2016 Apr 11.
10
使用CHARMM36加和力场的NAMD、GROMACS、AMBER、OpenMM和CHARMM/OpenMM模拟的CHARMM-GUI输入生成器。
J Chem Theory Comput. 2016 Jan 12;12(1):405-13. doi: 10.1021/acs.jctc.5b00935. Epub 2015 Dec 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验